FEDERAL STREET STRATEGIES, LLC

Lobbying for ABBVIE, INC. · Biopharmaceutical Research & Development Company.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Oct 20, 2025

Lobbying activity 2

Health Issues

Patient Access to drug treatment therapies; and drug cost and drug pricing reform. Oversight of the pharmaceutical industry and drug pricing. Monitoring policies as they relate to PBMs Monitor issues related to the FY2026 budget process

Medicare/Medicaid

Medicare Part D policies. Monitoring Policies related to the 340b program. Issues related to the implementation of the Inflation Reduction Act Monitor issues related to the FY2026 budget process

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.